(prop-2-en-1-yl)({[3-(trifluoromethyl)phenyl]methyl})amine, 95.0%, 2g

1-[4-(morpholine-4-sulfonyl)-2-nitrophenyl]pyrrolidine-2-carboxylic acid, 98%, 100mg

6,7-DIMETHOXY-N-(3-PHENOXYPHENYL)QUINOLIN-4-AMINE, 95%, 50mg

(S)-1-(5-Nitropyridin-2-yl)pyrrolidin-3-amine hydrochloride, 95.0%, 1g

n-(5-Bromopyridin-2-yl)-4-methylbenzenesulfonamide, 97%, 5g

Ácido isonicotínico, mínimo 98%, para síntesis, 100 g, envase de plástico.

Bolsas de eliminación SEKUROKA® PP, extrafuerte 100 ?m, 700 x 1100 mm, 75 unidades

2,5-Bis(4-bromophenyl)-1,1-dimethyl-3,4-diphenylsilole>95.0%(GC)1g

1-Amino-3,6,9,12-tetraoxapentadecan-15-oic acid, 95.0%, 1g

6-(2,6-DICHLOROPHENYL)-8-METHYL-2-(METHYLTHIO)PYRIDO[2,3-D]PYRIMIDIN-7(8H)-IMINE, 95.0%, 250mg

ISOORIENTIN, 99%, 250mg

Urapidil, 95.0%, 1g

Acetato de plomo(II), básico, mínimo 33 % PbO, PA, ACS, 25 g, envase de plástico.